California · Nonprofit
PROSTATE CANCER FOUNDATION
PROSTATE CANCER FOUNDATION (California) receives grants from 637 organizations whose IRS filings report $166,704,668 to it, the largest being VIOLA FOUNDATION INC ($30,410,000). 347 of them have funded it in more than one year.
- Revenue FY2024
- $57M
- Funders on record
- 637
- Grants received
- $167M
- Net assets
- $46M
What Prostate Cancer Foundation does
Mission
The Prostate Cancer Foundation (pcf) funds the world's most promising research on the biology and treatment of prostate cancer, accelerating those discoveries into therapies and strategies designed to improve the quality of life and overall survival of patients. Pcf is committed to the mission of ending death and suffering from the disease.
As stated on its FY2024 Form 990.
Programs
The pcf research enterprise is a peer-review research funding program that provides funding to 2,250 scientists conducting innovative research projects at more than 245 leading cancer centers and universities. Priority is given to high-risk, high-return projects with the greatest potential to improve survival and the overall quality of life for men with prostate cancer. The cornerstone of the pcf research enterprise in 2024 was our challenge awards program and new tactical awards program, which support cross-disciplinary teams of investigators conducting pioneering research to address critical unmet medical needs for prostate cancer patients. In 2024, pcf funded 15 multi-year team research projects that each offer high potential for improved detection, enhanced quality of life and higher survival rates.
$27,088,259 spentof which $27,088,259 as grants54% of program spendingFor more than 3 million american men and their families fighting prostate cancer and millions more globally, pcf serves as a primary source for new standard-of-care and research information. Pcf educates the public about prostate cancer risks, screening, prevention, treatment options, and side effects. We connect patients, loved ones, care providers, and scientists to critical updates, the latest developments, best practices, and news from the treatment pipeline. Since pcf's inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. Pcf aims to spur men and women alike to talk about this disease, to understand its urgency, and to have information-driven hope.
$15,750,450 spent$2,687 earned by the program31% of program spendingPcf created the young investigator award program with one goal: to build a gifted cohort of human capital supporting the next generation of prostate cancer researchers. Awards are made to early-career scientists working in a research environment capable of supporting high-impact prostate cancer research, drawn from a variety of medical research disciplines. In its 27th year, the pcf program has awarded nearly $93 million to advance the careers of 435 pcf young investigators, ensuring a continued stream of human capital into our research community. The pcf young investigator program plays an integral role in championing, mentoring, and identifying future medical research program leaders.
$6,209,630 spentof which $6,209,630 as grants12% of program spendingMore than 12,000 men cared for by the department of veterans affairs (va) hospitals are newly diagnosed with prostate cancer each year, making it the most frequently diagnosed cancer among veterans. The pcf-va partnership is expanding research into prostate cancer precision oncology treatment options. The collaboration is expanding the number of precision oncology clinical studies conducted at veterans health administration hospitals, ensuring that eligible veterans can access and participate in these studies. The va's precision oncology program for cancer of the prostate (popcap) was established in partnership with the Prostate Cancer Foundation 2016. The program uses genetic testing to find the best possible treatments for veterans with advanced prostate cancer. Popcap's network extends across the u.s. It includes 21 precision oncology centers of excellence, supplemented by regional centers, that provide cancer care to any veteran who develops prostate cancer, no matter where he lives.
$1,000,000 spentof which $1,000,000 as grants2% of program spending
The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $50,048,339.
The organization over time
Each line starts at 100 in 2020, so what you read is the shape rather than the size: 150 means half as much again as 2020, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $63M to $87M (+40%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 2% · 2021 2%. Grants only. Government contracts and fees sit inside program revenue.
95% of PROSTATE CANCER FOUNDATION’s revenue is contributions — more donation-reliant than the typical peer (80% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 5 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
Michael Milken
Founder & chairman
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 117 funders to 233 funders, grant income rose $14M → $29M.
57 of 637 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 22% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $5.1M from 4 payers (the payer shares this organization's board, largest The Michael and Lori Milken Family Foundation). These are real filings, and they are not money PROSTATE CANCER FOUNDATION raised.
From the IRS filings of PROSTATE CANCER FOUNDATION’s funders (the co-funder graph). Top 30 of 637 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
PROSTATE CANCER FOUNDATION has a broad base — no single funder exceeds 18% of grant income, and it takes 7 funders to reach half.
the vertical line marks half of all grant income — 7 funders to its left
33% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund PROSTATE CANCER FOUNDATION.
Largest funder’s share by year: 2017 35% · 2018 31% · 2019 13% · 2020 14% · 2021 19% · 2022 39% · 2023 35% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
38% of PROSTATE CANCER FOUNDATION's funders are still giving 3 years after their first grant; 54% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
PROSTATE CANCER FOUNDATION draws 77% of its grant income from funders outside California, across 43 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $37M arriving through sponsors registered in 24 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
PROSTATE CANCER FOUNDATION holds deeper cash reserves than three-quarters of the 828 philanthropy nonprofits its size.
this organization peer median middle 50% of peers· 828 philanthropy nonprofits $10M–$100M, FY2024
Organizations like PROSTATE CANCER FOUNDATION
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
86% of spending goes to programs.
Governance
Public support
85%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 37 states
Part of a family of 1 related entity
- Digital Science Press LLC · disregarded
Screen this organization
A dated, signed PDF of the compliance screen for PROSTATE CANCER FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds PROSTATE CANCER FOUNDATION?
- PROSTATE CANCER FOUNDATION (California) receives grants from 637 organizations whose IRS filings report $166,704,668 to it, the largest being VIOLA FOUNDATION INC ($30,410,000). 347 of them have funded it in more than one year.
- How many funders does PROSTATE CANCER FOUNDATION have?
- IRS filings report 637 organizations giving $166,704,668 in grants to PROSTATE CANCER FOUNDATION, 347 of which have funded it in more than one year.
- Who is the largest funder of PROSTATE CANCER FOUNDATION?
- VIOLA FOUNDATION INC is the largest funder on record, with $30,410,000 in grants. The full list of funders is on this page.
- How can an organization like PROSTATE CANCER FOUNDATION find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2020–2024), and the filings of 637 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing